Aspirin, salicylates, and cancer
Top Cited Papers
- 1 April 2009
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 373 (9671), 1301-1309
- https://doi.org/10.1016/s0140-6736(09)60243-9
Abstract
No abstract availableThis publication has 105 references indexed in Scilit:
- Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trialBritish Journal of Cancer, 2008
- Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studiesThe Lancet, 2007
- Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled TrialsAmerican Journal Of Medicine, 2006
- Low-Dose Aspirin in the Primary Prevention of CancerJAMA, 2005
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Can resistant starch and/or aspirin prevent the development of coloi neoplasia? The Concerted Action Polyp Prevention (CAPP) 1 StudyProceedings Of The Nutrition Society, 2003
- Breast cancer and NSAID use: a meta-analysisBritish Journal of Cancer, 2001
- ANTI-METASTATIC EFFECT OF ASPIRINThe Lancet, 1972
- Antimetastatic effects associated with platelet reduction.Proceedings of the National Academy of Sciences, 1968